Lieven Annemans explains the Value of Plasma Derived Therapies

The report provides a critical investigation into the clinical, economic, and societal dimensions of PDMPs, with a focus on improving patient access to these lifesaving medicines.

By focusing on formal and therapeutic patient access challenges, as well as challenges related to product availability, Vintura makes several key recommendations for industry and policymakers at the EU and Member State level to adopt in an effort to maximize patient access to PDMPs and societal benefits. The report was reviewed by Prof. Dr. Lieven Annemans, Senior Professor at the Faculty of Medicine at Ghent University, Belgium, and Prof. Marcin Czech, head of the Department of Pharmacoeconomics at the Institute of Mother and Child in Warsaw.

Want to know more about Plasma Derived Therapies? Vintura is a strategic consultancy company focusing on life sciences and healthcare sectors with a team of over 28 highly skilled consultants. Our experience in international markets allows us to support clients across Europe and beyond. Go to https://www.vintura.com/en/life-scien... or get in touch with Tomasz Kluszczynski